Skip to content

Feasibility and Acceptability Study of ACUAWARE

Collecting Pragmatic Data Via Electronic Health Records: ACUAWARE Feasibility and Acceptability Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06145997
Acronym
ACUAWARE
Enrollment
1
Registered
2023-11-24
Start date
2023-12-15
Completion date
2024-10-15
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Chronic pain, Feasibility study, Acceptability study

Brief summary

This study aims to gather preliminary feasibility and acceptability data to justify a subsequent trial that would fill a gap in knowledge regarding acupuncture therapy (AT) effects on interoceptive awareness (IA) among those with chronic pain.

Detailed description

This study aims to gather preliminary feasibility and acceptability data to justify a subsequent trial that would fill a gap in knowledge regarding acupuncture's effects on interoceptive awareness among individuals with chronic pain. Our primary hypotheses are that (1) Feasibility: it is feasible for us to enroll and retain 70% of the patients and it is feasible to collect data from at least 70% of participants at 3-months follow-up, and (2) Acceptability: it is acceptable for 70% of licensed acupuncturists to use Acu-Track Registry; it is acceptable for 70% of patients to complete questionnaires emailed to them via Acu-Track Registry. The investigators propose to evaluate these hypotheses by conducting a prospective, pragmatic single-arm feasibility and acceptability study among individuals with chronic pain of any etiology or location, except if due to cancer. Chronic pain is defined as pain that persists or recurs for more than 3 months.

Interventions

OTHERAcupuncture therapy

Acupuncture therapy (AT) is delivered by Licensed Acupuncturists (LAcs). Treatment plans are determined according to each patient's presentation and resulting traditional East Asian medicine (TEAM) differential diagnosis. TEAM therapeutics include AT, Chinese herbal medicine (CHM), Kampo herbal medicine, gua sha, tui na, cupping and lifestyle advice. All TEAM therapeutics are allowed in this study because it is a pragmatic, effectiveness study.

Sponsors

Pace University
CollaboratorOTHER
University of Utah
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patients: * Age 18 or older; * experiencing chronic pain, * complaint of 3+ months, * score of 5 or greater on a 1-10 scale; * able to provide informed consent * willing to sign an approved consent form that conforms to federal and institutional guidelines, * English speaking and writing.

Exclusion criteria

Prior or current diagnosis of: * cancer, * Multiple Sclerosis (MS), * any Dementia, * Parkinson's Disease, * Autism Spectrum Disorder, * Pregnancy, * Fibromyalgia, * Eating Disorder, * Down's Syndrome * Schizophrenia

Design outcomes

Primary

MeasureTime frameDescription
Feasibility metrics - rate of enrollment24 monthsRate of enrollment of acupuncturists and patients (frequency count)
Feasibility metrics - rate of retention24 monthsRate of retention of acupuncturists and participants (frequency count)
Feasibility metrics - rate of questionnaire completion24 monthsRate of questionnaire completion by participants (frequency count)
Feasibility metrics - completion rate of acupuncture therapy24 monthsRate of completion of acupuncture therapy (AT) (frequency count)
Feasibility metrics - rate of serious adverse events24 monthsRate of serious adverse events (frequency count)
Acceptability metrics24 monthsAcceptability ratings by licensed acupuncturists and by participants. Acceptability is asked in a binary question: Is it acceptable to you to use the Acu-Track registry? Yes/No. We define acceptable as 70% or more of licensed acupuncturists to use Acu-Track Registry; and acceptable for 70% or more of patients to complete questionnaires emailed to them via Acu-Track Registry.

Secondary

MeasureTime frameDescription
Multidimensional Assessment of Interoceptive Awareness Scale, 2 (MAIA-2)24 monthsThe MAIA-2, or Multidimensional Assessment of Interoceptive Awareness Scale, will be used to measure interoceptive awareness (IA). The MAIA-2 is comprised of 8 subscales and 37 items. Items are scored 0-5, with higher scores indicating increased IA.
Irritability24 monthsPROMIS-10 scoring allows each of the individual items to be examined separately to provide specific information about perceptions of health. We are using the single item: In the past 7 days: How often have you been bothered by emotional problems such as feeling irritable? Likert type scale 0-10: (0) no pain to (10) worst pain imaginable.
Global Impression of Change (GIC)24 monthsThis simple 1 question measure is a retrospective rating scale that asks the patient how much better or worse their health complaint is since beginning their course of treatments or care. It is a quick and straightforward way to gauge a patient's own belief about their improvement so far. Our PGIC scale is health complaint specific, rather than general, providing the ability to focus on monitoring a specific problem.
Physical Function from Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS-10)24 monthsPROMIS-10 scoring will be used to evaluate physical function. PROMIS-10 scoring allows each of the individual items to be examined separately to provide specific information about perceptions of health (e.g., physical function, pain, fatigue, emotional distress, social health and general perceptions of health). We are using the single item: To what extent are you able to carry out your everyday physical activities such as walking, climbing stairs, carrying groceries, or moving a chair? Likert type scale 5-1: (5) completely, to (1) not at all.
Global Mental Health24 monthsPROMIS-10 scoring will also be used to evaluate global mental health. We are using the single item: In the past 7 days: How often have you been bothered by emotional problems such as feeling anxious, depressed, or irritable? Likert type scale 0-10: (0) no pain to (10) worst pain imaginable
Anxiety24 monthsPROMIS-10 scoring allows each of the individual items to be examined separately to provide specific information about perceptions of health. We are using the single item: In the past 7 days: How often have you been bothered by emotional problems such as feeling anxious? Likert type scale 0-10: (0) no pain to (10) worst pain imaginable.
Depression24 monthsPROMIS-10 scoring allows each of the individual items to be examined separately to provide specific information about perceptions of health. We are using the single item: In the past 7 days: How often have you been bothered by emotional problems such as feeling depressed? Likert type scale 0-10: (0) no pain to (10) worst pain imaginable.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026